Has enough time passed to determine if CMI prevents re-ops of partial meniscectomies in a meaningful way?
GB:That’s a good question John, and as you know this is a question that be-devils orthopedics. Surgeons think in five-year blocks. From a company standpoint, it’s tough to follow these products for that long. What we do know is we have a feasibility study that included eight patients. These patients allowed the surgeon to conduct an arthroscopic re-look procedure at six years. JM: That’s impressive. GB: It was also impressive that the tissue was as viable in six years as it was in one year. This has been reported in an article that has been accepted for an upcoming issue of the Journal of Arthroscopy, which is expected to be published in the next six months. It will report that not only has the tissue remained constant over that time, but the patient activity level has increased. JM: How does CMI regenerate tissue (volume gain)? GB: The volume gain for a CMI patient is about twice what the patient had post partial meniscectomy [75% vs. 38%]. The mechanism for growth is that the collage
